Causes of Subchorionic Hemorrhage
Subchorionic hemorrhage results from hemorrhage around the gestational sac with blood accumulating between the chorion and myometrium, though the exact etiology remains incompletely understood. 1
Primary Pathophysiologic Mechanism
The fundamental process involves separation of the chorion from the decidua basalis, leading to blood accumulation in this potential space 2. This appears as a crescentic avascular collection adjacent to the chorion on ultrasound, typically hypoechoic or anechoic 1.
Established Risk Factors and Associated Conditions
Coagulation Abnormalities
The most strongly supported etiologic factors involve maternal coagulation dysfunction:
- Decreased protein S activity 3
- Reduced antithrombin-III levels 3
- Elevated homocysteine levels 3
- Maternal factor deficiency (the only definitively established risk factor) 4
- Anticoagulation therapy (the other definitively established risk factor) 4
Autoimmune Factors
Multiple autoantibodies are associated with increased SCH risk 3:
- Lupus anticoagulant
- Anticardiolipin antibodies
- Antinuclear antibodies
- Anti-β2 glycoprotein 1 antibodies 5
- Rheumatoid factor IgM 5
Notably, patients with SCH who test positive for autoantibodies have significantly higher miscarriage rates (28.2% vs 7.6%) compared to those without autoantibodies 3.
Assisted Reproductive Technology
IVF pregnancies have significantly higher rates of subchorionic hematoma (22.4%) compared to spontaneous conceptions (11%) 6. Within IVF pregnancies, specific risk factors include:
Additional Contributing Factors
- Abnormal placenta formation and implantation 3
- Reproductive tract infection 2
- Drug use during pregnancy 2
- Recurrent pregnancy loss history 5
Immunologic Dysregulation
Recent predictive modeling identified specific immune markers associated with SCH 5:
- Altered serum immunoglobulin IgG levels
- Complement C3 abnormalities
- Interleukin-2/Interleukin-6 ratio alterations
- Interferon-γ/Interleukin-6 ratio changes
Clinical Context
Subchorionic hematomas are relatively common, occurring in approximately 18-22% of patients with live intrauterine pregnancies and vaginal bleeding in the first trimester 1. While traditionally thought to increase pregnancy loss risk, several recent studies suggest there may not be an independent increased risk of pregnancy loss 1.
Important Caveats
The exact pathogenesis remains unclear despite extensive research 2. The occurrence likely represents a multifactorial process involving abnormal coagulation, immune dysfunction, and placental implantation abnormalities rather than a single causative mechanism. No uniform clinical treatment guidelines exist because the underlying etiology varies between patients 2.